Asthma and allergy

Asthma and COVID-19 risk: a systematic review and meta-analysis
Anthony P. Sunjaya, Sabine M. Allida, Gian Luca Di Tanna, Christine R. Jenkins

European Respiratory Journal Mar 2022, 59 (3) 2101209; DOI: 10.1183/13993003.01209-2021
Anti-IL5 mepolizumab minimally influences residual blood eosinophils in severe asthma
Glenn Van Hulst, Joseph Jorssen, Nathalie Jacobs, Monique Henket, Renaud Louis, Florence Schleich, Fabrice Bureau, Christophe J. Desmet

European Respiratory Journal Mar 2022, 59 (3) 2100935; DOI: 10.1183/13993003.00935-2021
Obesity, tidal volume, and pulmonary deposition of fine particulate matter in children with asthma
Nima Afshar-Mohajer, Tianshi David Wu, Rebecca Shade, Emily Brigham, Han Woo, Megan Wood, Rachelle Koehl, Kirsten Koehler, Jason Kirkness, Nadia N. Hansel, Gurumurthy Ramchandran, Meredith C. McCormack

European Respiratory Journal Mar 2022, 59 (3) 2100209; DOI: 10.1183/13993003.00209-2021
Novel mechanisms of action contributing to benralizumab's potent anti-eosinophilic activity
Rania Dagher, Varsha Kumar, Alan M. Copenhaver, Sandra Gallagher, Mahboobe Ghaedi, Jonathan Boyd, Paul Newbold, Alison A. Humbles, Roland Kolbeck

European Respiratory Journal Mar 2022, 59 (3) 2004306; DOI: 10.1183/13993003.04306-2020
Plasma proteins elevated in severe asthma despite oral steroid use and unrelated to Type-2 inflammation
Maria Sparreman Mikus, Johan Kolmert, Lars I. Andersson, Jörgen Östling, Richard G. Knowles, Cristina Gómez, Magnus Ericsson, John-Olof Thörngren, Payam Emami Khoonsari, Barbro Dahlén, Maciej Kupczyk, Bertrand De Meulder, Charles Auffray, Per S. Bakke, Bianca Beghe, Elisabeth H. Bel, Massimo Caruso, Pascal Chanez, Bo Chawes, Stephen J. Fowler, Mina Gaga, Thomas Geiser, Mark Gjomarkaj, Ildikó Horváth, Peter H. Howarth, Sebastian L. Johnston, Guy Joos, Norbert Krug, Paolo Montuschi, Jacek Musial, Ewa Niżankowska-Mogilnicka, Henric K. Olsson, Alberto Papi, Klaus F. Rabe, Thomas Sandström, Dominick E. Shaw, Nikolaos M. Siafakas, Mathias Uhlén, John H. Riley, Stewart Bates, Roelinde J.M. Middelveld, Craig E. Wheelock, Kian Fan Chung, Ian M. Adcock, Peter J. Sterk, Ratko Djukanovic, Peter Nilsson, Sven-Erik Dahlén, Anna James

European Respiratory Journal Feb 2022, 59 (2) 2100142; DOI: 10.1183/13993003.00142-2021
Prenatal tobacco exposure and risk of asthma and allergy outcomes in childhood
Rikke Bjersand Sunde, Jonathan Thorsen, Casper-Emil Tingskov Pedersen, Jakob Stokholm, Klaus Bønnelykke, Bo Chawes, Hans Bisgaard

European Respiratory Journal Feb 2022, 59 (2) 2100453; DOI: 10.1183/13993003.00453-2021
Glucocorticoid toxicity reduction with mepolizumab using the Glucocorticoid Toxicity Index
P. Jane McDowell, John H. Stone, Yuqing Zhang, Kirsty Honeyford, Louise Dunn, R. Jayne Logan, Lorcan P.A. McGarvey, Claire A. Butler, Liam G. Heaney

European Respiratory Journal Jan 2022, 59 (1) 2100160; DOI: 10.1183/13993003.00160-2021
Stopping versus continuing long-term mepolizumab treatment in severe eosinophilic asthma (COMET study)
Wendy C. Moore, Oliver Kornmann, Marc Humbert, Claude Poirier, Elisabeth H. Bel, Norihiro Kaneko, Steven G. Smith, Neil Martin, Martyn J. Gilson, Robert G. Price, Eric S. Bradford, Mark C. Liu

European Respiratory Journal Jan 2022, 59 (1) 2100396; DOI: 10.1183/13993003.00396-2021
Long-term modulation of airway remodelling in severe asthma following bronchial thermoplasty
Nicholas Jendzjowsky, Austin Laing, Michelle Malig, John Matyas, Elaine de Heuvel, Curtis Dumonceaux, Elaine Dumoulin, Alain Tremblay, Richard Leigh, Alex Chee, Margaret M. Kelly

European Respiratory Journal Jan 2022, 59 (1) 2100622; DOI: 10.1183/13993003.00622-2021
The effect of tezepelumab on airway hyperresponsiveness to mannitol in asthma (UPSTREAM)
Asger Sverrild, Susanne Hansen, Morten Hvidtfeldt, Carl-Magnus Clausson, Olga Cozzolino, Samuel Cerps, Lena Uller, Vibeke Backer, Jonas Erjefält, Celeste Porsbjerg

European Respiratory Journal Jan 2022, 59 (1) 2101296; DOI: 10.1183/13993003.01296-2021

Main menu

User menu

Search

Asthma and allergy

Pages

Contact us